Page Loader Image
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
Public Pharma For Europe
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact

Medical research without patents: It’s preferable, it’s profitable, and it’s practicable

Author: Radder, H., & Smiers, R.

Date: 2024

Language: English

Learn More: https://doi.org/10.1080/08989621.2024.2324913

POSTS PPFE (9)
2
3
POSTS PPFE (10)
5
6
7
8

You might also enjoy

La política del medicamento en la UE y su renuncia a la salud global

Read More »

The European Pharmaceutical Package Agreement: an insufficient step that preserves industry privileges and fails to guarantee equitable access to medicines

Read More »

New $55 Insulin Pens Mark Step in California’s Fight Against Insulin Price Gouging

Read More »

The UK must defend drug price controls

Read More »

The pandemic accord: new possibilities for public health industrialisation pathways?

Read More »

Greed Is a Hell of a Drug

Read More »